We aspiring to reshape the Saudi pharmaceutical industry.

Diversified Specialty Portfolio is our ultimate aspiration

Oncology Project

SPC idea came to build a Cancer Chemotherapeutics facility based on the unmet need for a specialized manufacturing plant that focuses on the manufacturing of highly specialized and technically advanced pharmaceutical products to create a new pharmaceutical industrial era in KSA and MENA region and to be the 1st Saudi.
Oncology specialized pharmaceutical company with a manufacturing facility in KSA. Oncology market volume is almost 2.57 Bn SR in 2019 , with consistent CAGR of 6%, expected to reach 2.73 Bn SR in 2020. Project’s scope is to be a partner with the government in decreasing the expenditure of the healthcare sector via the provision of products with International Standard Quality and Affordable Prices. The production area is 2,826.90 m2 & the Storage area is 1,848.60 m2. Refrigerated stores area (2 to 8 °C) is 70.30 m2. Manufacturing Capacity (Production Lines):
  • Tablets Produced per year: 20 million Tablets.
  • Capsules produced per year: 4 million Capsules.
  • Liquid (Sterile) Vials: 3.5 million vials.
  • Lyophilized Vials: 3.1 million Vials.

Vaccines Project

The size of the vaccine market in Saudi Arabia is about $400 million annually, while biological medicines represent $1 billion with an approximate annual growth rate of 15 percent.
This project aims to improve the immunity of the Saudi population through the provision of national standard quality vaccines.

Respiratory Project

Prevalence rate of respiratory diseases in Saudi Arabia has witnessed an increase in the last decade where COPD rate reached 4.2% of the total population and 14.2% among smokers.
The global respiratory diseases drugs market is expected to grow from $65 billion in 2019 to $92.6 billion in 2020 at a compound annual growth rate (CAGR) of 42.5%.
The unmet need in the Saudi Market arises from the necessity of having a National pharmaceutical company that could provide these products with high quality and affordable prices to secure the local availability as well as reducing the costs of these important medications that serve a large patients’ base.
Our Scope is complete manufacturing of respiratory medications and devices locally in Saudi Arabia including Inhalers, Nebulization products and nasal sprays through international partnerships.

Biotechnology Project

The US$250 billion global biologics market has exhibited a double-digit growth in the past 5 years, and this is expected to continue.
The ability of biologics to cure multiple life-threatening diseases has contributed to this significant growth. However, the high cost is a major restraint for their adoption, especially in cost-conscious healthcare systems such as emerging markets.
SPC is taking the responsibility of localizing the manufacturing of such sensitive and important products to support all the Saudi patients in having better health and to ensure the national security of those medications.